Childhood nail psoriasis: a useful treatment with tazarotene 0.05%.

Author(s): Diluvio L, Campione E, Paterno EJ, Mordenti C, El Hachem M, Chimenti S

Affiliation(s): Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. lauradiluvio@yahoo.it

Publication date & source: 2007-05, Pediatr Dermatol., 24(3):332-3.

Publication type: Case Reports

Nail psoriasis occurs in 7% to 40% of children, with a similar pattern of clinical presentation to that of adults. In 0.6% to 2.3% of the patients nail changes appear as the only sign of the disease, preceding other skin and articular involvement. No pediatric clinical trials are available yet, but considering the successful use of tazarotene for nail dystrophy therapy in adults, we chose this drug to treat a child.